Mail & Guardian
Mail & Guardian
arvlatest news & developments
In South Africa, lack of adherence to HIV treatment remains a problem.

HIV responses succeed when we let communities lead

The Nomakhayas of Nqileni in the Eastern Cape give us a case study to replicate This content is restricted to registered users and subscribers. Get Your Free Account The Mail &…

Youngsters huddle together in a group hug at Nkosi’s Haven following their morning warm-up. (Gemma Ritchie)

Learning to find peace on the stage

artInsideOut launched an intensive three-week theatre course aimed at helping children use creativity to handle setbacks.

?A number of universities are rolling out critical antiretroviral therapy medication to their students living with HIV. (David Harrison)

Universities offer HIV treatment

On-campus clinics roll out ARTs to students to improve access and decrease stigma

Community health workers didn’t just provide at-home HIV testing. They went into schools to help teach young people sexual and reproductive health and encourage boys to get medically circumcised. (MSF)

#AIDS2016: How a rural community helps each other stay on HIV treatment

An adherence club helped almost all patients stay on their treatment.

South Africa may still need donor support to fund expanded ARV roll out in the country.

#AIDS2016: SA pays its HIV bill but faces budget gap for expanded treatment

Research predicts a substantial shortfall in HIV funding in the next five years as the country looks to put millions more people on treatment.

Fela Gucci: “We’re already trying to survive so much”.

First ARVs from state-owned pharmaceutical company expected by 2017

As the world’s biggest consumer of ARVs, South Africa spends billions of rands purchasing the drugs on the international market every year.

From critical condition to stable

The nation’s healthcare system reflects the actions of the ministers responsible for it over the years.

Bhekisisa director Mia Malan speaks on The Science Inside show about ARV shortages on Voice of Wits radio station.

ARV-shortages uncovered: Bhekisisa director speaks on VoW FM

Bhekisisa director Mia Malan speaks on The Science Inside show about ARV shortages on Voice of Wits radio station.

‘ … The point is that the majority of women in Voice didn’t use any of the study products as recommended

New HIV infections in SA fall by a third since 2004

Between 2004 and 2012, the number of new HIV infections have decreased from an estimated 540 000 to 370 000, shows a UNAids report.

The outcome of the ANC’s long-awaited KwaZulu-Natal conference was a win for the Thuma Mina crowd. (Delwyn Verasamy/M&G)

Drug row sparked by HIV spending

A new study to be conducted in South Africa, Uganda and India has sparked a heated debate in the HIV activist and research community.

Bhekisisa director Mia Malan speaks on The Science Inside show about ARV shortages on Voice of Wits radio station.

ARV plan bounces back

The hunt is on for a new private sector partner with the expertise to set up a drug-making plan.

Truth serum: The M&G Bhekisisa centre aims to avoid disseminating myths.

Comment: Ignorant reporting can be lethal

As the fallout regarding misinformation about vaccines and antiretrovirals shows, words can kill.

State consolidates HIV treatment

New medicine combines ARVs into one pill, making them easier to supply.

Khetukthula Hlongwane was told at her local clinic to buy her own ARVs because it had run out.

Why has Gauteng run out of ARVs?

Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.

Drop in infections follows ARVs’ success

ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN

HIV-positive Swazis protest over sick service

HIV-positive Swazis protest over sick service

Hundreds of people with HIV took to the streets of Swaziland to protest over poor health service delivery and a reported shortage of ARV treatment.

Hole in Zuma’s HIV plan

Health economists say increasing the uptake of antiretroviral treatment to meet the state’s targets will require an additional R10bn a year in funding

Cash crisis hits Aids fund

The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion